The biological and diagnostic roles of MicroRNAs in meningiomas

Author:

Wang Lei1,Chen Shengpan23,Liu Yan4,Zhang Hongqi23,Ren Nianjun1,Ma Ruoyu5,He Zhengwen1

Affiliation:

1. Department of Neurosurgery , Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University , Changsha , Hunan , China

2. Department of Neurosurgery , Xuanwu Hospital, Capital Medical University , Beijing , China

3. International Neuroscience Institute of China (China-INI) , Beijing , China

4. Department of Neurology , Changsha Central Hospital , Changsha , Hunan , China

5. Xiangya School of Medicine, Central South University , Changsha , Hunan , China

Abstract

Abstract MicroRNAs (miRNAs) refer to a class of small endogenous non-coding RNAs that regulate gene expression at the post-transcriptional level. Emerging studies have shown that miRNAs play critical roles in tumorigenesis and cancer progression. However, roles and mechanisms of miRNA dysregulation in the pathogenesis of meningioma are not fully understood. Here, we first reviewed existing research of aberrantly expressed miRNAs identified by high throughput microarray profiling in meningioma. We also explored the potential of miRNA as biomarkers and therapeutic targets for novel treatment paradigms of meningiomas. In addition, we summarized recent researches that focused on the possible mechanisms involved in miRNA-mediate meningioma occurrence and progression. This review provides an overview of miRNA deregulation in meningioma and indicates the potential of miRNAs to be used as biomarkers or novel therapeutic targets.

Funder

National Key R&D Program of China

Hunan Provincial Natural Science Foundation of China

Scientific Research Project of Hunan Provincial Health Commission

China Postdoctoral Science Foundation

Science Research Foundation of Hunan Provincial Education Department

Hunan Cancer Hospital Climb Plan

Publisher

Walter de Gruyter GmbH

Subject

General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3